跳至主要内容
临床试验/CTIS2023-509607-32-00
CTIS2023-509607-32-00招募中1 期

ithium versus Lamotrigine in bipolar disorder, type II – a single blinded randomized controlled trial (the LiLa-Bipolar RCT)

Psykiatrisk Center Kobenhavn0 个研究点目标入组 200 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • All patients referred to the clinic as newly diagnosed with BDII will routinely be asked for inclusion in the RCT. Patients are included during 1) depressive state, 2) hypomanic state or 3) full or partial remission., Bipolar disorder, type II with diagnoses confirmed by SCAN interview, Age 18-65 years, Speaks and writes Danish at a level equal to mother tongue, Habile (i.e., able to give informed consent)

排除标准

  • Past non-response or intolerance to lamotrigine or lithium with > 6 weeks treatment at an adequate dosage, Currently taking mod stabilizers at enrollment in CADIC, Chronic kidney disease with GFR 0-10 ml/min, Severe cardiac insufficiency (NYHA IIIb-IV), Brugadas syndrome, Severe hypothyroidism despite treatment

研究者

发起方
Psykiatrisk Center Kobenhavn

相似试验